MARKETS

Demand for peritoneal dialysis solutions and sterile infusion products is steadily increasing, driven by:

• The growing prevalence of chronic kidney diseases
• Demographic trends, particularly aging populations
• The expansion of home-based dialysis therapies
• The increasing outsourcing of pharmaceutical production to CDMOs

Industry Context
At the same time, specialized GMP production capacity for dialysis solutions in Europe remains limited, particularly for flexible and innovation-driven manufacturing requirements.

Customer Segments
Newsol PD collaborates with:

• Medical technology companies developing dialysis systems
• Pharmaceutical and biotechnology companies requiring GMP manufacturing
• Dialysis providers and healthcare institutions